Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Newmark Group
NMRK
$2.12B
| $5.39M | ﹤0.01% |
1,110,040
-210,272
| -16% | -$884K |
2019 Q4
2 quarters
|
|
1602
Reynolds Consumer Products
REYN
$4.65B
| $5.38M | ﹤0.01% |
+155,000
| New | +$5.05M |
2020 Q2
0 quarters
|
|
1603
Integer Holdings
ITGR
$4.3B
| $5.38M | ﹤0.01% |
73,700
+68,900
| +1,435% | +$5.01M |
2020 Q1
1 quarter
|
|
|
ZVO
1604
DELISTED
Zovio Inc. Common Stock
ZVO
| $5.37M | ﹤0.01% |
1,755,306
-70,863
| -4% | -$161K |
2013 Q2
28 quarters
|
|
1605
Crawford & Co Class A
CRD.A
$600M
| $5.37M | ﹤0.01% |
680,224
+9,800
| +1% | +$66.4K |
2013 Q2
28 quarters
|
|
1606
Cactus
WHD
$4.47B
| $5.37M | ﹤0.01% |
260,100
-271,800
| -51% | -$4.71M |
2018 Q3
7 quarters
|
|
1607
Home Bancorp
HBCP
$518M
| $5.36M | ﹤0.01% |
200,200
-15,200
| -7% | -$372K |
2013 Q2
28 quarters
|
|
1608
iShares MSCI China ETF
MCHI
$5.96B
| $5.35M | ﹤0.01% |
+81,800
| New | +$5.02M |
2020 Q2
0 quarters
|
|
1609
Manitowoc
MTW
$813M
| $5.33M | ﹤0.01% |
489,798
+296,600
| +154% | +$2.81M |
2020 Q1
1 quarter
|
|
1610
ITT
ITT
$18B
| $5.32M | ﹤0.01% |
90,500
+45,066
| +99% | +$2.39M |
2019 Q3
3 quarters
|
|
1611
Lantheus
LNTH
$6.53B
| $5.31M | ﹤0.01% |
371,611
-885,989
| -70% | -$11.7M |
2016 Q2
16 quarters
|
|
1612
Aclaris Therapeutics
ACRS
$511M
| $5.31M | ﹤0.01% |
3,279,840
+104,204
| +3% | +$140K |
2018 Q4
6 quarters
|
|
1613
Genie Energy
GNE
$445M
| $5.3M | ﹤0.01% |
720,397
+108,500
| +18% | +$850K |
2013 Q2
28 quarters
|
|
1614
Western Alliance Bancorporation
WAL
$8.04B
| $5.3M | ﹤0.01% |
140,002
-139,802
| -50% | -$4.89M |
2020 Q1
1 quarter
|
|
1615
AC Immune
ACIU
$239M
| $5.29M | ﹤0.01% |
786,011
+108,700
| +16% | +$790K |
2017 Q4
10 quarters
|
|
1616
Purple Innovation
PRPL
$8.59M
| $5.29M | ﹤0.01% |
11,756
+7,260
| +161% | +$2.29M |
2019 Q3
3 quarters
|
|
1617
Tsakos Energy Navigation Ltd
TEN
$1.7B
| $5.28M | ﹤0.01% |
525,361
-124,920
| -19% | -$1.72M |
2013 Q2
28 quarters
|
|
1618
Mitek Systems
MITK
$761M
| $5.28M | ﹤0.01% |
549,081
+244,900
| +81% | +$2.21M |
2019 Q1
5 quarters
|
|
1619
Rhythm Pharmaceuticals
RYTM
$5.96B
| $5.26M | ﹤0.01% |
235,900
+141,200
| +149% | +$2.75M |
2019 Q3
3 quarters
|
|
1620
Bombardier Recreational Products
DOO
$3.77B
| $5.26M | ﹤0.01% |
123,500
-337,500
| -73% | -$10.1M |
2018 Q4
6 quarters
|
|
1621
51Talk Online Education Group
COE
$65.6M
| $5.25M | ﹤0.01% |
51,125
+25,625
| +100% | +$2.55M |
2019 Q1
5 quarters
|
|
|
CLDR
1622
DELISTED
Cloudera, Inc.
CLDR
| $5.24M | ﹤0.01% |
411,852
-2,407,600
| -85% | -$23.1M |
2019 Q4
2 quarters
|
|
1623
Huntington Ingalls Industries
HII
$10.2B
| $5.24M | ﹤0.01% |
30,000
+21,300
| +245% | +$3.96M |
2020 Q1
1 quarter
|
|
1624
Yum China
YUMC
$14.5B
| $5.24M | ﹤0.01% |
108,900
-740,700
| -87% | -$34.9M |
2017 Q1
13 quarters
|
|
|
GRP.U
1625
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $5.23M | ﹤0.01% |
101,300
+16,700
| +20% | +$782K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.